NeoTX Therapeutics Ltd.

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharma

Revolution Medicines Inc. continued this year’s biopharmaceutical initial public offering trend by closing well above its IPO price on its first day of trading. In fact, investors have been so intrig

Active Biotech AB / Teva Pharmaceutical Industries Ltd. 's oral immunomodulator, laquinimod, has failed to show efficacy in another potential indication, Huntington's disease, with the mainly negative

IN VITRO DIAGNOSTICS Mergers & Acquisitions Oxford Immunotec Global PLC Immunetics Inc. Oxford Immunotec Global PLC is paying $6mm in cash to acquire Immunetics Inc. (immunoassays for infectio